‘Little bit early’ to say Moderna is the ‘savior’ in the COVID-19 vaccine race: Analyst

Yahoo Finance’s Akiko Fujita and Jared Holz, Healthcare Equity Strategy at Jefferies, discuss competition for a COVID-19 vaccine as AstraZeneca strikes a deal with the U.S. for an antibody treatment. …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.